NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Science Virtual Investor ...

Kezar Life Sciences Announces Presentation of PORTOLA Data at the American Association for the Study of Liver Disease (AASLD) – The Liver Meeting® 2025 Kezar Life Sciences, Inc. (Nasdaq: KZR), a ...

Presentation to highlight WVE-007 (INHBE GalNAc-siRNA) as a potential novel and unique obesity treatment leading to healthy weight loss and supporting preclinical data demonstrating potent and durable ...

NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of ...

Shares of biotechnology company Wave Life Sciences rose as it held its Annual Research Day, detailing its work in RNA editing and RNAi for conditions including Alpha-1 antitrypsin deficiency and ...

Returning for its fourth year, Bisnow’s International Life Sciences & Biotech Conference returns to San Diego in 2026. As the global life sciences industry continues to drive innovation, this two-day ...

When I returned to Philadelphia in early 2016, after more than 20 years on the West Coast, the life sciences community here was gaining momentum. A decade later, some of that grassroots enthusiasm has ...

To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com. About Virtual Investor Conferences® ...